Literature DB >> 1669488

Body fat distribution, blood pressure, and hypertension. A prospective cohort study of men in the normative aging study.

P A Cassano1, M R Segal, P S Vokonas, S T Weiss.   

Abstract

The relation between the abdominal accumulation of body fat, blood pressure, and hypertension was assessed prospectively among 1972 male participants in the Veterans Administration Normative Aging Study. Body mass index (BMI = weight [kg]/height [m]2) and the ratio of abdominal circumference to hip breadth (AC/HB), measured at regular exams, were used as indices of total adiposity and body fat distribution, respectively. Considering blood pressure as a continuous outcome variable (in models that allowed for intraclass correlation), the AC/HB ratio was significantly positively associated with both diastolic and systolic blood pressure (P < 0.001), adjusting for age and BMI. Blood pressure was dichotomized and hypertension risk was assessed using the proportional hazards model, adjusting for age and BMI. Seven hundred cases of hypertension were recorded by study physicians during 35,496 person-years of follow-up. The risk of hypertension increased approximately three-fold (95% confidence interval, 1.7 to 5.2) with a change of one unit in the AC/HB ratio. These estimates were little changed when the effects of smoking and alcohol intake were considered. Thus, the abdominal accumulation of body fat, apart from overall level of adiposity, was associated with both increased blood pressure and an increased risk of hypertension.

Entities:  

Mesh:

Year:  1990        PMID: 1669488     DOI: 10.1016/1047-2797(90)90017-m

Source DB:  PubMed          Journal:  Ann Epidemiol        ISSN: 1047-2797            Impact factor:   3.797


  44 in total

Review 1.  Obesity-related hypertension: role of the sympathetic nervous system, insulin, and leptin.

Authors:  Kazuko Masuo
Journal:  Curr Hypertens Rep       Date:  2002-04       Impact factor: 5.369

2.  Race/ethnic and sex differentials in pulse pressure among us adults.

Authors:  Richard G Rogers; Jarron M Saint Onge
Journal:  Ethn Dis       Date:  2005       Impact factor: 1.847

3.  Relations of body weight status in early adulthood and weight changes until middle age with hypertension in the Chinese population.

Authors:  Long Zhou; Ying Li; Min Guo; Yangfeng Wu; Liancheng Zhao
Journal:  Hypertens Res       Date:  2016-06-30       Impact factor: 3.872

4.  Effectiveness of a community pharmacy weight management programme.

Authors:  Helen F Boardman; Anthony J Avery
Journal:  Int J Clin Pharm       Date:  2014-06-11

5.  Obesity induces neuroinflammation mediated by altered expression of the renin-angiotensin system in mouse forebrain nuclei.

Authors:  Annette D de Kloet; David J Pioquinto; Dan Nguyen; Lei Wang; Justin A Smith; Helmut Hiller; Colin Sumners
Journal:  Physiol Behav       Date:  2014-02-06

Review 6.  The pathophysiology of hypertension in patients with obesity.

Authors:  Vincent G DeMarco; Annayya R Aroor; James R Sowers
Journal:  Nat Rev Endocrinol       Date:  2014-04-15       Impact factor: 43.330

Review 7.  Neuroimmune communication in hypertension and obesity: a new therapeutic angle?

Authors:  Annette D de Kloet; Eric G Krause; Peng D Shi; Jasenka Zubcevic; Mohan K Raizada; Colin Sumners
Journal:  Pharmacol Ther       Date:  2013-02-28       Impact factor: 12.310

Review 8.  Role of body fat distribution and the metabolic complications of obesity.

Authors:  Michael D Jensen
Journal:  J Clin Endocrinol Metab       Date:  2008-11       Impact factor: 5.958

9.  A retrospective cohort study on obesity and hypertension risk among Korean adults.

Authors:  Sung-Hee Lee; Young-Sik Kim; Sung Sunwoo; Bong-Yul Huh
Journal:  J Korean Med Sci       Date:  2005-04       Impact factor: 2.153

10.  Adiponectin protects against incident hypertension independent of body fat distribution: observations from the Dallas Heart Study.

Authors:  Poghni A Peri-Okonny; Colby Ayers; Naim Maalouf; Sandeep R Das; James A de Lemos; Jarett D Berry; Aslan T Turer; Ian J Neeland; Philipp E Scherer; Wanpen Vongpatanasin
Journal:  Diabetes Metab Res Rev       Date:  2016-08-18       Impact factor: 4.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.